Kroger, the world’s largest food retailer, has hired a former associate director of vaccine programs for the Centers for Disease Control and Prevention to work as a vaccine coordinator for the company’s vaccine rollout.
Dr. Daniel A. Schmitt, a veteran doctor who spent 15 years at the CDC, was the acting director of the CDC’s National Center for Immunization and Respiratory Diseases from November 2013 to January 2015, according to a Kroggea spokeswoman.
He was confirmed as acting director in February, and Kroger announced the appointment on Wednesday.
A Kroger spokeswoman said the appointment was “a strategic move to further position the Kroger brand as a leader in vaccine technology” and help drive greater public awareness of the vaccine.
Kroger also has a partnership with the American Heart Association, which also has its own vaccine team.
Schmitt joined Kroger in 2012 after nearly two decades as a senior medical director in the CDC.
Krogges vaccine directorate was part of the agency’s immunization program, which oversees the production of vaccines and supplies to hospitals, clinics and health care facilities.
Schiffs role in Kroger’s vaccine team has not been announced.
Schitt joined Kroggers vaccine team in April of 2015, when the company was still known as Kroger Health Products.
He has been the director of Kroger Vaccines since February.
In 2014, he was the director and principal vaccine designer for Pfizer’s new, long-awaited vaccine for the human immunodeficiency virus (HIV).
Schmitt also worked for Pfister in Germany, where the company has been developing vaccines for the virus, before returning to the United States.
Schindts current role at Pfizer is to lead vaccine development and safety in Europe and Asia.
The Kroger vaccines will be manufactured by Genentech, a company that is also working on Pfizer vaccines for human immunocompromise.
Krogers vaccine division has been involved in other vaccine projects, including a vaccine for pneumococcal meningitis and a vaccine developed by Roche, the manufacturer of the vaccines used in the flu vaccine, according the Krog’s public relations website.
In May, Schmitt resigned from Pfizer and its vaccine division, saying he was stepping down to focus on his health.
Pfizer said he was resigning to focus his efforts on his family.
Schmidt is the latest vaccine coordinator to leave a company after a vaccine rollout, including the resignation of an associate director at the FDA’s Centers for Devices and Radiological Health.
In August, a CDC director resigned after a CDC vaccine coordinator left the agency after serving for nearly four years.
Schindts resignation came just a day after a pharma company, Merck, said it was ending its vaccine development program after more than a decade of work.
Merck had been developing a vaccine to fight the H1N1 influenza pandemic.